Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01862-18. Print 2019 Apr 15.
A clinical isolate of measles virus (MeV) bearing a single amino acid alteration in the viral fusion protein (F; L454W) was previously identified in two patients with lethal sequelae of MeV central nervous system (CNS) infection. The mutation dysregulated the viral fusion machinery so that the mutated F protein mediated cell fusion in the absence of known MeV cellular receptors. While this virus could feasibly have arisen via intrahost evolution of the wild-type (wt) virus, it was recently shown that the same mutation emerged under the selective pressure of small-molecule antiviral treatment. Under these conditions, a potentially neuropathogenic variant emerged outside the CNS. While CNS adaptation of MeV was thought to generate viruses that are less fit for interhost spread, we show that two animal models can be readily infected with CNS-adapted MeV via the respiratory route. Despite bearing a fusion protein that is less stable at 37°C than the wt MeV F, this virus infects and replicates in cotton rat lung tissue more efficiently than the wt virus and is lethal in a suckling mouse model of MeV encephalitis even with a lower inoculum. Thus, either during lethal MeV CNS infection or during antiviral treatment , neuropathogenic MeV can emerge, can infect new hosts via the respiratory route, and is more pathogenic (at least in these animal models) than wt MeV. Measles virus (MeV) infection can be severe in immunocompromised individuals and lead to complications, including measles inclusion body encephalitis (MIBE). In some cases, MeV persistence and subacute sclerosing panencephalitis (SSPE) occur even in the face of an intact immune response. While they are relatively rare complications of MeV infection, MIBE and SSPE are lethal. This work addresses the hypothesis that despite a dysregulated viral fusion complex, central nervous system (CNS)-adapted measles virus can spread outside the CNS within an infected host.
一个麻疹病毒(MeV)的临床分离株,其病毒融合蛋白(F)上发生了单一的氨基酸改变(L454W),此前在两名患有致命性 MeV 中枢神经系统(CNS)感染后遗症的患者中被发现。该突变使病毒融合机制失调,使得突变的 F 蛋白在没有已知的 MeV 细胞受体的情况下介导细胞融合。虽然这种病毒可能是通过野生型(wt)病毒在宿主内进化而来,但最近表明,在小分子抗病毒治疗的选择压力下,同样的突变也出现了。在这些条件下,一种潜在的神经致病性变体出现在 CNS 之外。虽然 MeV 的 CNS 适应被认为会产生更不适合宿主间传播的病毒,但我们表明,两种动物模型可以通过呼吸道很容易地被 CNS 适应的 MeV 感染。尽管该病毒的融合蛋白在 37°C 时不如 wt MeV F 稳定,但它在棉鼠肺组织中的感染和复制效率比 wt 病毒更高,并且在用较低接种量的 MeV 脑炎乳鼠模型中是致死性的。因此,无论是在致命性 MeV CNS 感染期间还是在抗病毒治疗期间,神经致病性 MeV 都可能出现,可以通过呼吸道感染新的宿主,并且比 wt MeV 具有更高的致病性(至少在这些动物模型中)。麻疹病毒(MeV)感染在免疫功能低下的个体中可能很严重,并导致包括麻疹包涵体脑炎(MIBE)在内的并发症。在某些情况下,即使存在完整的免疫反应,MeV 也会持续存在并导致亚急性硬化性全脑炎(SSPE)。虽然它们是 MeV 感染的相对罕见的并发症,但 MIBE 和 SSPE 是致命的。这项工作验证了一个假说,即尽管病毒融合复合物失调,中枢神经系统(CNS)适应的麻疹病毒仍可以在受感染宿主的 CNS 之外传播。